View ValuationADM Tronics Unlimited 将来の成長Future 基準チェック /06現在、 ADM Tronics Unlimitedの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長17.3%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.お知らせ • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、ADM Tronics Unlimited は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:ADMT - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20253000N/A9/30/20253000N/A6/30/20253000N/A3/31/20253000N/A12/31/202430-1-1N/A9/30/202430-1-1N/A6/30/202430-1-1N/A3/31/20243-1-1-1N/A12/31/20233-1-1-1N/A9/30/20233-100N/A6/30/20234000N/A3/31/20234000N/A12/31/20224-100N/A9/30/20224-100N/A6/30/20223-100N/A3/31/20223-100N/A12/31/20213-1-1-1N/A9/30/20213-1-1-1N/A6/30/20213-1-1-1N/A3/31/20213-1-1-1N/A12/31/202030-1-1N/A9/30/202030-10N/A6/30/20203000N/A3/31/20203000N/A12/31/20193000N/A9/30/201930N/A0N/A6/30/201930N/A0N/A3/31/201930N/A0N/A12/31/201830N/A0N/A9/30/201830N/A0N/A6/30/201830N/A0N/A3/31/201840N/A0N/A12/31/201740N/A0N/A9/30/201750N/A0N/A6/30/201751N/A0N/A3/31/201751N/A0N/A12/31/201651N/A1N/A9/30/201651N/A1N/A6/30/201651N/A1N/A3/31/201651N/A1N/A12/31/201541N/A1N/A9/30/201541N/A1N/A6/30/201531N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ADMTの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: ADMTの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: ADMTの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: ADMTの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: ADMTの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ADMTの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/26 09:26終値2026/05/26 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ADM Tronics Unlimited, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.
お知らせ • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.